tiprankstipranks
Halma plc (GB:HLMA)
:HLMA

Halma plc (HLMA) AI Stock Analysis

Compare
52 Followers

Top Page

GBHalma plc
(LSE:HLMA)
80Outperform
Halma plc scores well due to robust financial performance and positive earnings call outcomes, reflecting strong growth and strategic execution. However, the high valuation and moderate technical indicators slightly temper the overall score. Key strengths include revenue growth and cash flow management, while challenges in specific sectors and a high P/E ratio pose risks.
Positive Factors
Financial Performance
Financial performance has been strong from Halma over the past 12 months, and the shares have moved up accordingly.
Growth Potential
Halma expects another strong year of free cash flow, which continues to give headroom for acquisitions to show good momentum through the fiscal year.
Negative Factors
Revenue Dependency
A single customer in the Environmental & Analysis division accounts for 14% of group revenue, suggesting materially more concentration risk in this portfolio business.

Halma plc (HLMA) vs. S&P 500 (SPY)

Halma plc Business Overview & Revenue Model

Company DescriptionHalma plc is a global group of life-saving technology companies, with a focus on sectors including safety, health, and environmental markets. The company operates through four main segments: Process Safety, Infrastructure Safety, Environmental & Analysis, and Medical. Halma's core products and services include hazard detection and life protection products, water and environmental analysis products, and medical devices used to enhance the quality of life.
How the Company Makes MoneyHalma plc generates revenue primarily through the sale of its diverse range of products and services across its four business segments. In Process Safety, the company earns from providing products that protect assets and people at work, such as gas detection and pipeline monitoring systems. The Infrastructure Safety segment contributes to revenue by offering fire and smoke detectors, security sensors, and elevator safety products. The Environmental & Analysis segment provides water and environmental monitoring products, which are sold to generate income. The Medical segment brings in revenue through the sale of health assessment and diagnostic equipment, as well as devices for patient treatment and care. Halma's earnings are bolstered by strategic acquisitions, which expand its technological capabilities and market reach, as well as by fostering long-term relationships with key customers and partners.

Halma plc Financial Statement Overview

Summary
Halma plc demonstrates strong financial health with consistent revenue growth, solid profitability margins, and effective cash flow management. While the balance sheet displays a prudent leverage strategy, the rising debt levels warrant careful monitoring.
Income Statement
85
Very Positive
Halma plc has demonstrated a solid performance in its income statement. The gross profit margin stands at 49.7% for the latest year, indicating strong profitability. The company’s net profit margin improved to 13.2%, reflecting efficient cost management. Revenue growth has been consistent, with a 9.8% increase from the previous year. EBIT and EBITDA margins are robust at 18.1% and 23.4%, respectively, showcasing operational efficiency.
Balance Sheet
78
Positive
The balance sheet of Halma plc shows a healthy financial position. The debt-to-equity ratio is 0.46, suggesting a balanced approach to leverage. The return on equity is strong at 15.5%, indicating effective use of shareholders' funds. The equity ratio is 57.9%, demonstrating a stable capital structure with a good proportion of assets financed by equity. However, the increase in total debt over time could pose a risk if not managed carefully.
Cash Flow
82
Very Positive
Cash flow analysis reveals positive trends for Halma plc. The company has achieved substantial free cash flow growth of 70.7% over the previous year, reflecting strong cash generation capabilities. The operating cash flow to net income ratio is 1.43, indicating efficient conversion of income to cash. Additionally, the free cash flow to net income ratio is 1.24, further highlighting the company's ability to generate cash relative to its earnings.
Breakdown
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
2.03B1.85B1.53B1.32B1.34B
Gross Profit
1.01B877.90M724.30M613.60M631.30M
EBIT
367.70M321.50M284.80M252.30M245.60M
EBITDA
476.70M411.30M401.80M354.00M320.60M
Net Income Common Stockholders
268.80M234.50M244.40M203.40M184.40M
Balance SheetCash, Cash Equivalents and Short-Term Investments
142.70M169.50M157.40M134.10M106.30M
Total Assets
3.00B2.79B2.20B1.88B1.94B
Total Debt
795.90M766.20M432.20M390.30M481.60M
Net Debt
653.20M596.70M274.80M256.20M375.30M
Total Liabilities
1.26B1.19B792.80M709.60M800.20M
Stockholders Equity
1.74B1.60B1.40B1.17B1.14B
Cash FlowFree Cash Flow
333.40M195.30M189.40M226.20M196.10M
Operating Cash Flow
385.00M241.20M229.40M268.40M244.90M
Investing Cash Flow
-287.50M-369.60M-134.90M-65.00M-276.90M
Financing Cash Flow
-119.70M138.50M-73.70M-173.50M64.80M

Halma plc Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2770.00
Price Trends
50DMA
2836.72
Negative
100DMA
2718.22
Positive
200DMA
2626.38
Positive
Market Momentum
MACD
-20.87
Positive
RSI
38.06
Neutral
STOCH
17.71
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:HLMA, the sentiment is Neutral. The current price of 2770 is below the 20-day moving average (MA) of 2884.75, below the 50-day MA of 2836.72, and above the 200-day MA of 2626.38, indicating a neutral trend. The MACD of -20.87 indicates Positive momentum. The RSI at 38.06 is Neutral, neither overbought nor oversold. The STOCH value of 17.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:HLMA.

Halma plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
£10.49B36.4815.48%0.79%11.94%20.48%
78
Outperform
£6.77B27.6011.21%2.15%3.13%13.36%
68
Neutral
£5.90B45.6114.56%1.32%13.59%6.14%
GBRSW
67
Neutral
£2.06B21.0810.72%2.62%4.71%0.43%
62
Neutral
$8.11B13.341.17%3.02%4.16%-15.14%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:HLMA
Halma plc
2,770.00
484.81
21.22%
GB:SMIN
Smiths Group plc
1,995.00
417.82
26.49%
GB:DPLM
Diploma
4,400.00
1,031.14
30.61%
GB:RSW
Renishaw
2,830.00
-1,422.04
-33.44%

Halma plc Earnings Call Summary

Earnings Call Date: Nov 21, 2024 | % Change Since: 11.07% | Next Earnings Date: Jun 12, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong performance with record revenue and profit, driven by organic growth and strategic acquisitions. However, challenges in the Healthcare sector and currency headwinds were notable issues.
Highlights
Record Revenue and Profit
Revenue exceeded GBP1 billion and EBIT surpassed GBP200 million for the first time, with double-digit increases in both revenue and profit.
Strong Organic Growth and Margins
The company reported organic revenue growth of 11.5% and an EBIT margin improvement of 70 basis points to 20.7%.
M&A Momentum and Investment
Seven acquisitions made year-to-date with a total spend of GBP158 million, contributing more than 4% to EBIT growth.
High Cash Conversion and Low Debt
Cash conversion at 108%, net debt to EBITDA reduced slightly to 1.27.
Sector-Specific Achievements
Safety sector profit up 20% with margin expansion of 190 basis points; Environmental & Analysis sector saw 27% revenue growth.
Lowlights
Healthcare Sector Challenges
Healthcare sector reported a decline of 2.5% on an OCCY basis, with a significant margin decrease of 260 basis points.
Weakness in Europe
Revenue in Europe declined 1% due to weak healthcare performance, primarily in eye health therapeutics.
Currency Headwinds
Currency drag of 1.6% on revenue and 1.9% on EBIT due to the strengthening of sterling.
Company Guidance
In the recent call, Halma provided comprehensive guidance on its financial performance for the first half of fiscal year 2025. The company reported record revenue exceeding GBP1 billion and EBIT surpassing GBP200 million for the first time, reflecting a 13% increase in revenue and a 17% rise in adjusted EBIT. The EBIT margin improved by 70 basis points to 20.7%, while the return on total invested capital (ROTIC) rose by 110 basis points to 14.3%. Organic revenue growth was 11.5%, with acquisitions contributing 3.5% to revenue growth. Cash conversion was strong at 108%, and net debt to EBITDA decreased slightly to 1.27. The interim dividend was increased by 7%, supported by high cash generation and a strong balance sheet. The company emphasized its ongoing commitment to investing in future growth through R&D and acquisitions, with a total acquisition spend of GBP158 million year-to-date. Looking ahead, Halma expects to deliver an adjusted EBIT margin of around 21% and good organic constant currency revenue growth for the full year, supported by a healthy M&A pipeline across all three sectors.

Halma plc Corporate Events

Executive/Board Changes
Halma plc Announces Executive Share Award Transaction
Neutral
Feb 28, 2025

Halma plc announced a transaction involving the grant of a Performance Share Award under the Executive Share Plan to Carole Cran, the Chief Financial Officer Designate. This transaction, involving 54,301 ordinary shares, reflects the company’s commitment to aligning managerial interests with shareholder value, potentially impacting its operational focus and stakeholder confidence.

Halma plc Announces Share Transactions by Key Personnel
Jan 14, 2025

Halma plc has disclosed a notification in accordance with the Market Abuse Regulation, revealing share transactions by key managerial personnel. Sharmila Nebhrajani, a Non-Executive Director, purchased 187 ordinary shares, while Carole Cran, the Chief Financial Officer Designate, acquired 8,000 shares. These transactions indicate confidence in Halma’s market positioning and may impact stakeholder perceptions positively.

Halma Announces CFO Transition, Strengthens Leadership for Growth
Jan 8, 2025

Halma plc has announced a leadership transition with the retirement of Chief Financial Officer (CFO) Steve Gunning, effective March 31, 2025. Carole Cran, an experienced finance leader and current non-executive director at Halma, has been appointed as CFO Designate and will officially assume the role on April 1, 2025. This change aligns with the company’s succession plans, ensuring continued focus on strategic growth and operational excellence. The appointment is expected to bolster Halma’s financial leadership, leveraging Cran’s extensive experience and familiarity with the company’s sustainable growth model. This transition is significant for stakeholders as it underscores Halma’s commitment to maintaining robust governance and financial stewardship.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.